501 related articles for article (PubMed ID: 30027839)
1. Recent Advances in Drug Repurposing for Parkinson's Disease.
Chen X; Gumina G; Virga KG
Curr Med Chem; 2019; 26(28):5340-5362. PubMed ID: 30027839
[TBL] [Abstract][Full Text] [Related]
2. Validating the Predicted Effect of Astemizole and Ketoconazole Using a Drosophila Model of Parkinson's Disease.
Styczyńska-Soczka K; Zechini L; Zografos L
Assay Drug Dev Technol; 2017 Apr; 15(3):106-112. PubMed ID: 28418693
[TBL] [Abstract][Full Text] [Related]
3. Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease.
Bortolanza M; Nascimento GC; Socias SB; Ploper D; Chehín RN; Raisman-Vozari R; Del-Bel E
J Neural Transm (Vienna); 2018 Oct; 125(10):1403-1415. PubMed ID: 30109452
[TBL] [Abstract][Full Text] [Related]
4. Drug Repurposing in Parkinson's Disease.
Athauda D; Foltynie T
CNS Drugs; 2018 Aug; 32(8):747-761. PubMed ID: 30066310
[TBL] [Abstract][Full Text] [Related]
5. Old wines in new bottles: Repurposing opportunities for Parkinson's disease.
Kakkar AK; Singh H; Medhi B
Eur J Pharmacol; 2018 Jul; 830():115-127. PubMed ID: 29689247
[TBL] [Abstract][Full Text] [Related]
6. CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity.
Parsons CG
Neuropharmacology; 2019 Mar; 147():4-10. PubMed ID: 30165077
[TBL] [Abstract][Full Text] [Related]
7. Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
Johnston TH; Lacoste AMB; Visanji NP; Lang AE; Fox SH; Brotchie JM
Neuropharmacology; 2019 Mar; 147():11-27. PubMed ID: 29907424
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
9. Drug repurposing strategies of relevance for Parkinson's disease.
Fletcher EJR; Kaminski T; Williams G; Duty S
Pharmacol Res Perspect; 2021 Aug; 9(4):e00841. PubMed ID: 34309236
[TBL] [Abstract][Full Text] [Related]
10. Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease.
Bourque M; Morissette M; Di Paolo T
Neuropharmacology; 2019 Mar; 147():37-54. PubMed ID: 29649433
[TBL] [Abstract][Full Text] [Related]
11. Advances and challenges in the dosage form design for the treatment of Parkinson's disease.
Wen MM
Discov Med; 2012 Dec; 14(79):369-77. PubMed ID: 23272689
[TBL] [Abstract][Full Text] [Related]
12. Current approaches to the treatment of Parkinson's Disease.
Ellis JM; Fell MJ
Bioorg Med Chem Lett; 2017 Sep; 27(18):4247-4255. PubMed ID: 28869077
[TBL] [Abstract][Full Text] [Related]
13. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Konreddy AK; Rani GU; Lee K; Choi Y
Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
[TBL] [Abstract][Full Text] [Related]
14. Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems.
Garbayo E; Ansorena E; Blanco-Prieto MJ
Maturitas; 2013 Nov; 76(3):272-8. PubMed ID: 23827471
[TBL] [Abstract][Full Text] [Related]
15. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
16. Current Approaches and Tools Used in Drug Development against Parkinson's Disease.
Koszła O; Stępnicki P; Zięba A; Grudzińska A; Matosiuk D; Kaczor AA
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208760
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in drug repositioning for the discovery of new anticancer drugs.
Shim JS; Liu JO
Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Aviles-Olmos I; Limousin P; Lees A; Foltynie T
Brain; 2013 Feb; 136(Pt 2):374-84. PubMed ID: 22344583
[TBL] [Abstract][Full Text] [Related]
19. Advances in drug development for Parkinson's disease: present status.
Harikrishna Reddy D; Misra S; Medhi B
Pharmacology; 2014; 93(5-6):260-71. PubMed ID: 25096413
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective strategies in Parkinson's disease : an update on progress.
Mandel S; Grünblatt E; Riederer P; Gerlach M; Levites Y; Youdim MB
CNS Drugs; 2003; 17(10):729-62. PubMed ID: 12873156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
